HLN (Haleon plc American Depositary Shares (Each representing two Ordinary Shares)) Stock Analysis - AI Report

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) is a publicly traded Healthcare sector company. As of May 20, 2026, HLN trades at $9.28 with a market cap of $40.62B and a P/E ratio of 0.00. HLN moved +0.92% today. Year to date, HLN is -8.21%; over the trailing twelve months it is -15.79%. Its 52-week range spans $8.71 to $11.42. Analyst consensus is buy with an average price target of $13.92. Rallies surfaces HLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on HLN?

Rallies AI research for HLN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

HLN Key Metrics

Key financial metrics for HLN
MetricValue
Price$9.28
Market Cap$40.62B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.13%
52-Week High$11.42
52-Week Low$8.71
Volume7.49M
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest HLN News

HLN Analyst Consensus

1 analysts cover HLN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.92.

Common questions about HLN

What is the AI research view on HLN?
Rallies AI research for HLN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for HLN?
Rallies AI research for HLN combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is HLN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HLN. It does not provide personalized investment advice.
HLN

HLN